PhD, Health Policy
Harvard University
SM, Population and International Health
Harvard University
AB, History
Dartmouth College
Publications
The economic costs and cost-effectiveness of HIV self-testing among truck drivers in Kenya.
March 2024 | Health Policy and Planning
Implementation of “Treat-all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey.
July 2019 | Journal of the International AIDS Society
Research priorities to inform “Treat All” policy implementation for people living with HIV in sub-Saharan Africa: A consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA).
January 2019 | Journal of the International AIDS Society
Mathematical modelling to inform ‘treat all’ implementation in sub-Saharan Africa: A scoping review.
November 2018 | Journal of Virus Eradication
Implementing parallel spreadsheet models for health policy decisions: The impact of unintentional errors on model projections.
March 2018 | PLoS ONE
HIV prevention resources: Time to move toward affordability.
February 2017 | Lancet HIV
Clinical outcomes of HIV care delivery models in the US: A systematic review.
October 2016 | AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV
Performance of a mathematical model to forecast lives saved from HIV treatment expansion in resource-limited settings.
February 2015 | Medical Decision Making
Home HIV testing and counselling: Answers raising questions.
November 2014 | Lancet HIV
Lives saved by expanding HIV treatment availability in resource-limited settings: The example of Haiti.
June 2013 | Journal of Acquired Immune Deficiency Syndromes
Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability.
September 2012 | Cost Effectiveness and Resource Allocation
Decision maker priorities for providing antiretroviral therapy in HIV-infected South Africans: A qualitative assessment.
February 2012 | AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV
WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: Modeling clinical outcomes in infants and mothers.
June 2011 | PLoS One
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: A cost-effectiveness analysis of the OCTANE trial.
February 2011 | AIDS
Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA.
February 2011 | HIV Medicine
Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India.
September 2010 | PLoS One
Assessing the performance of a computer-based policy model of HIV and AIDS.
September 2010 | PLoS One
Test and treat DC: Forecasting the impact of a comprehensive HIV strategy in Washington DC.
August 2010 | Clinical Infectious Diseases
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: Clinical benefits and cost-effectiveness.
July 2010 | Journal of Acquired Immune Deficiency Syndromes
Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d’Ivoire appraisal.
October 2009 | PLoS Medicine
When to start antiretroviral therapy in resource-limited settings.
August 2009 | Annals of Internal Medicine
Scaling up antiretroviral therapy in South Africa: The impact of speed on survival.
May 2008 | Journal of Infectious Diseases
Cost-effectiveness of HIV treatment in resource-poor settings–the case of Côte d’Ivoire.
September 2006 | New England Journal of Medicine
Diagnostic tests in HIV management: A review of clinical and laboratory strategies to monitor HIV-infected individuals in developing countries.
July 2006 | Bulletin of the World Health Organ
Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease.
May 2005 | Journal of Acquired Immune Deficiency Syndromes
Routine human immunodeficiency virus testing: An economic evaluation of current guidelines.
March 2005 | The American Journal of Medicine
Expanded screening for HIV in the United States–an analysis of cost-effectiveness.
February 2005 | New England Journal of Medicine
Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients.
January 2005 | Antiviral Therapy
Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection.
December 2003 | The American Journal of Medicine
Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy.
December 2002 | Antiviral Therapy
Treatment for primary HIV infection: Projecting outcomes of immediate, interrupted, or delayed therapy.
September 2002 | Journal of Acquired Immune Deficiency Syndromes
The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality.
August 2002 | Journal of Acquired Immune Deficiency Syndromes
Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: Using simulation modeling to inform clinical guidelines.
April 2002 | Archives of Internal Medicine